Concepedia

Publication | Open Access

Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina

DOIFull Paper Access

11

Citations

23

References

2024

Year

Gonzalo Guiñazú, Julia Dvorkin, Sarwat Mahmud, Ranju Baral, Clint Pecenka, Romina Libster, Andrew Clark, Mauricio T. Caballero
Vaccine

Abstract

Either RSV mAb or maternal RSV vaccine are worth consideration in Argentina when priced at ≤US$ 50 per dose. A seasonal strategy could improve cost-effectiveness.

References

YearCitations

Page 1